Interactions between CYP11B2 Promoter Methylation and Smoking Increase Risk of Essential Hypertension

Abstract EN

Aldosterone synthase (CYP11B2) is closely linked to essential hypertension (EH).

However, it remains unclear whether the methylation of the CYP11B2 promoter is involved in the development of EH in humans.

Our study is aimed at evaluating the contribution of CYP11B2 promoter methylation to the risk of EH.

Methylation levels were measured using pyrosequencing technology in 192 participants in a hospital-based case-control study.

Logistic regression and multiple linear regression analyses were utilized to adjust for confounding factors and the GMDR method was applied to investigate high-order gene-environment interactions.

Although no significant result was observed linking the four analyzed CpG sites to EH, GMDR detected significant interactions among CpG1, CpG3, CpG4, and smoking correlated with an increased risk of EH (OR = 4.62, adjusted P=0.011).

In addition, CpG2 (adjusted P=0.013) and CpG3 (adjusted P=0.039) methylation was significantly lower in healthy males than in healthy females.

Likewise, after adjusting for confounding factors, CpG2 methylation (adjusted P=0.007) still showed significant gender-specific differences among the participants of the study.

CpG1 (P=0.009) site was significantly positively correlated with age, and CpG3 (P=0.007) and CpG4 (P=0.006) were both inversely linked to smoking.

Our findings suggest that gene-environment interactions are associated with the pathogenesis and progression of EH.